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Caveolins are a crucial component of plasma membrane (PM) caveolae but have also been localized to intracellular
compartments, including the Golgi complex and lipid bodies. Mutant caveolins associated with human disease show
aberrant trafficking to the PM and Golgi accumulation. We now show that the Golgi pool of mainly newly synthesized
protein is detergent-soluble and predominantly in a monomeric state, in contrast to the surface pool. Caveolin at the PM
is not recognized by specific caveolin antibodies unless PM cholesterol is depleted. Exit from the Golgi complex of
wild-type caveolin-1 or -3, but not vesicular stomatitis virus-G protein, is modulated by changing cellular cholesterol
levels. In contrast, a muscular dystrophy-associated mutant of caveolin-3, Cav3P104L, showed increased accumulation in
the Golgi complex upon cholesterol treatment. In addition, we demonstrate that in response to fatty acid treatment
caveolin can follow a previously undescribed pathway from the PM to lipid bodies and can move from lipid bodies to the
PM in response to removal of fatty acids. The results suggest that cholesterol is a rate-limiting component for caveolin
trafficking. Changes in caveolin flux through the exocytic pathway can therefore be an indicator of cellular cholesterol and
fatty acid levels.
INTRODUCTION
Caveolins have been well studied as structural components
of plasma membrane (PM) caveolae. Moreover, caveolins
have been described in the Golgi complex (Kurzchalia and
Parton, 1999; Gkantiragas et al., 2001); the endoplasmic re-
ticulum (ER)/Golgi network (Smart et al., 1994); cis-Golgi
cisternae (Luetterforst et al., 1999); trans-Golgi network
(TGN)-derived vesicles of epithelial cells (Kurzchalia et al.,
1992; Scheiffele et al., 1998); cytosolic lipid bodies (Fujimoto
et al., 2001; Ostermeyer et al., 2001; Pol et al., 2001); endo-
somes (Pol et al., 1999; Gagescu et al., 2000); and in a novel
endocytic compartment, the caveosome (Pelkmans et al.,
2001; Nichols, 2003). Little is known about whether these
proteins can, under physiological conditions, cycle to/from
these intracellular compartments. Conformational changes
of the caveolin protein, and possibly the interaction with
other proteins or lipids, have complicated analysis of the
tracking of the protein between different cellular pools (Du-
pree et al., 1993; Luetterforst et al., 1999; Nomura and Fuji-
moto, 1999). Caveolin is a fatty acid- and cholesterol-binding
protein. It can be phosphorylated on several residues, ap-
parently interacts with a long and diverse list of proteins,
and forms high-molecular-weight homo- and hetero-oli-
gomers (Monier et al., 1995; Murata et al., 1995; Sargiacomo
et al., 1995; Trigatti et al., 1999). Questions also remain about
the importance of a soluble form of caveolin-1 and the role
of cytosolic trafficking in caveolin dynamics (Uittenbogaard
et al., 1998). Real-time studies of caveolins have overcome
some of these difficulties but vary in their conclusions re-
garding caveolin dynamics and trafficking (Mundy et al.,
2002; Thomsen et al., 2002). Generally, the surface pool of
caveolin-1 seems to be relatively immobile unless cells are
perturbed experimentally (e.g., okadaic acid addition or ac-
tin depolymerization) or cells are incubated with viruses
that cause caveolae (and caveolin-1) internalization (Parton
et al., 1994; Pelkmans et al., 2001). However, a Golgi pool of
caveolin has been well-documented and implicated in epi-
thelial sorting (Kurzchalia et al., 1992; Dupree et al., 1993).
The importance of understanding caveolin trafficking is ev-
ident from the finding that aberrant caveolin trafficking
underlies human disease conditions. Caveolin-3 mutants as-
sociated with human muscle disease conditions such as limb
girdle muscular dystrophy type 1C accumulate within the
Golgi complex and act in a dominant manner to perturb
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trafficking of wild-type caveolin-3 to the PM (Galbiati et al.,
1999). For example, the P104L mutant of caveolin-3,
Cav3P104L, has a short half-life and undergoes ubiquitina-
tion and proteasome-dependent degradation (Galbiati et al.,
2000). An equivalent mutation in caveolin-1, P132L, was
reported to occur in 16% of human breast cancers and
shown to have similar aberrant trafficking (Hayashi et al.,
2001; Lee et al., 2002). The mechanisms underlying traffick-
ing of caveolin through the Golgi complex, the role of ve-
sicular versus cytosolic traffic, and the nature of the block in
trafficking of mutant caveolin proteins are presently un-
known. Moreover, recent studies showing that wild-type
(WT)-caveolin can associate with lipid bodies (LBs) in a
reversible and lipid-regulated manner (Pol et al., 2004) sug-
gests that caveolin can be directed into other trafficking
pathways.
In the present study, we have characterized a number of
antibodies that specifically label the intracellular pool of
the protein. We show that newly synthesized caveolins
transit the Golgi complex before being transported to the
PM. Exit from the Golgi complex and association with the
PM are accompanied by oligomerization, acquisition of
detergent insolubility, and masking of specific caveolin
epitopes; caveolin at the PM is not recognized by specific
caveolin antibodies unless cholesterol is depleted. More-
over, we now show that caveolin transport from the Golgi
complex can be regulated by lipids; transport of WT-
caveolins, but not the Cav3P104L mutant or a control
transmembrane protein, is accelerated by cholesterol ad-
dition. We also have characterized the trafficking of
caveolin to lipid bodies by using fluorescent caveolin
constructs and fluorescence recovery after photobleaching
(FRAP). Caveolin redistributes from the PM to LBs in
response to fatty acids, illuminating a novel pathway of
communication between these two compartments. In ad-
dition, caveolin within LBs can associate with the PM,
suggesting that caveolin can move bidirectionally be-
tween these two membrane systems in response to spe-
cific environmental stimuli.
MATERIALS AND METHODS
Plasmids, Antibodies, and Reagents
Cav3-green fluorescent protein (GFP) and Cav3P104L-GFP were generated as
described previously (Luetterforst et al., 1999). Vesicular stomatitis virus-G
protein (VSV-G)-GFP was kindly provided by Dr. J. Lippincott-Schwartz
(National Institutes of Health, Bethesda, MD). Primary caveolin antibodies
used in this work are summarized in Table 1. Mouse anti-GM130 was ob-
tained from BD Transduction Laboratories (Lexington, KY). Mouse and rabbit
anti-hemagglutinin (HA) were kindly provided by Prof. David James (Uni-
versity of Queensland, Queensland, Australia) and Dr. Tommy Nilsson (Eu-
ropean Molecular Biology Laboratory, Heidelberg, Germany). Gold-conju-
gated secondary antibodies were from Jackson ImmunoResearch Laboratories
(West Grove, PA). Alexa Fluor-conjugated secondary antibodies were from
Molecular Probes (Eugene, OR). Horseradish peroxidase (HRP)-conjugated
secondary antibodies were from Zymed Laboratories (South San Francisco,
CA). Cycloheximide (Cyhx), 2-hydroxypropyl--cyclodextrin (CD), filipin,
and water-soluble cholesterol (Chl) were purchased from Sigma-Aldrich (St.
Louis, MO).
Cell Culture and Cyhx/Cholesterol Treatments
Baby hamster kidney cells (BHK) and Vero cells were maintained in DMEM
with 10% (vol/vol) fetal calf serum (FCS) supplemented with 2 mM
l-glutamine, 50 U/ml penicillin, and 50 g/ml streptomycin sulfate. Then,
16 h before the experiments, the cells were split in fresh 10% FCS medium
supplemented with 2 mM l-glutamine. Cells were transfected using Lipo-
fectAMINE Plus (Invitrogen, Paisley, United Kingdom) according to the
manufacturer’s instructions. In some experiments, 10 g/ml Cyhx (from a 10
mg/ml stock solution in 100 mM HEPES, pH 7.5) was added directly to the
growth medium for different times. For cholesterol addition, cells were incu-
bated with 30 g/ml cholesterol prepared freshly from a powdered stock
(15.1 mg of cholesterol per gram of solid) and premixed at room temperature
for 30 min in DMEM by gentle agitation. When Cyhx and cholesterol (or CD)
were used in combination, both were dissolved in DMEM. For the experi-
ments performed at 15 or 20°C, Cyhx, CD, and cholesterol were dissolved in
CO2-independent medium (Invitrogen). For those experiments, control incu-
bations at 37°C also were performed in air medium but out of the CO2
incubator. Cyhx completely inhibited protein synthesis as judged by the lack
of any detectable fluorescence after expression of GFP in the presence of Cyhx
for 24 h. In some experiments, cells were preincubated in a medium contain-
ing 50 g/ml oleic acid (Calbiochem, San Diego, CA) conjugated with fatty
acid-free bovine serum albumin (Calbiochem) and incubated in the same
medium for the time of the transfection as described previously (Pol et al.,
2004).
Immunofluorescence Microscopy: Whole Cells
BHK cells grown on glass coverslips were fixed with either methanol (20°C
for 2 min) or 4% paraformaldehyde (PFA; room temperature for 1 h). PFA-
Table 1. Antibodies used in this work and summary of the specificity of the antibodies for the different pools of caveolin under different
fixation and permeabilization procedures (see text and Figure 1 for details)
Antibodies Caveolin pool detected
Classification Antibody Reference Method Golgi PM
Anti-Go-cav MoTL37120 BD Transduction Laboratories C37120 PFA/saponin  
PFA/TX-100  
Methanol  
Con-cav Luetterforst et al. (1999) PFA/saponin  
PFA/TX-100  
Methanol  
MoZYMED Zymed Laboratories 03-6000 PFA/saponin  
PFA/TX-100  
Methanol  
Mocav2 BD Transduction Laboratories C57820 PFA/saponin  
PFA/TX-100  
Methanol  
Anti-PM-cav MoTL43420 BD Transduction Laboratories C43420 PFA/saponin  
PFA/TX-100  
Methanol  
Anti-cav RbTL BD Transduction Laboratories C13630 PFA/saponin  
PFA/TX-100  
Methanol  
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fixed cells were then washed twice in phosphate-buffered saline (PBS) and
permeabilized for 10 min with either 0.1% saponin (wt/vol) or 0.1% Triton
X-100 (TX-100) (vol/vol) at room temperature. They were then labeled as
described previously (Pol et al., 2004). Filipin staining was performed as
described previously (Pol et al., 2001). To quantify the fluorescence intensity,
images corresponding to the different treatments performed in parallel were
captured at the same contrast and intensity and the pixel intensity analyzed
using NIH Image software. A total of 200 cells from random fields were
analyzed for each treatment.
Immunofluorescence Microscopy: PM Sheets
For the preparation of PM sheets, 3T3-L1 adipocytes were grown and differ-
entiated on coverslips as described previously (Frost and Lane, 1985). Cells
were disrupted by sonication using a Sonifier 250 (Branson Ultratronics,
Danbury, CT) in cold sonication buffer (20 mM HEPES, pH 7.2, 120 mM
potassium glutamate, 20 mM potassium acetate, and 10 mM EGTA) supple-
mented with 0.5 mM dithiothreitol and 250 M phenylmethylsulfonyl fluo-
ride as described previously (Robinson et al., 1992). PM sheets were fixed
using either 4% PFA in PBS for 30 min at room temperature or methanol for
2 min at –20°C. For extraction of cholesterol, PM sheets were incubated in
sonication buffer in the absence or presence of 0.4% methyl--cyclodextrin for
30 min at 37°C before fixation in 4% PFA. Plasma membrane sheets were
labeled by indirect immunofluorescence microscopy as described previously.
Immunoprecipitation and Western Blotting
Seventy-five percent confluent, 6.5-cm dishes of BHK cells were washed twice
with cold PBS before being extracted for 2 min by immersion into 1 ml of
ice-cold 10 mM Tris, pH 7.5, 150 mM NaCl, and 5 mM EDTA, and protease
and phosphatase inhibitors, supplemented with 0.1% TX-100. Nuclei and
unbroken cells were removed of the soluble supernatant by centrifugation at
2000 rpm for 5 min at 4°C in an Eppendorf Microfuge. The amount of
extracted protein was quantified by the method of Bradford (1976). Two
micrograms of antibody was mixed with 120 g of sample in a final volume
of 500 l for 2 h at 4°C. Antibody/caveolin complexes were harvested using
40 l of protein A/G bound to Sepharose beads for an additional 45 min.
Finally, the complexes were pelleted and washed twice before eluting using
40 l of SDS-PAGE electrophoresis buffer. For Western blotting analysis,
equal volumes of each immunoprecipitation were electrophoretically sepa-
rated by SDS-PAGE in 12% polyacrylamide gels. Polypeptides were trans-
ferred to Immobilon membranes (Millipore, Billerica, MA), and proteins were
detected using specific antibodies diluted in PBS containing 2% nonfat dry
milk. After washing in PBS solution containing 0.1% Tween 20, primary
antibodies were detected by using HRP-conjugated secondary antibodies
diluted in 2.5% nonfat dry milk in PBS. Finally, the reaction was developed by
using the enhanced chemiluminescence system (Amersham Biosciences UK,
Little Chalfont, Buckinghamshire, United Kingdom).
Oligomerization Gradients
Seventy-five percent confluent 6.5-cm dishes of BHK cells were washed twice
with cold PBS before being extracted for 2 min by immersion into 1 ml of
ice-cold 10 mM Tris, pH 7.5, 150 mM NaCl, and 5 mM EDTA, and protease
and phosphatase inhibitors, supplemented with 0.1% TX-100. Nuclei and
unbroken cells were removed of the soluble supernatant by centrifugation at
2000 rpm for 5 min at 4°C in an Eppendorf Microfuge. Samples were loaded
at the top of discontinuous sucrose gradient ranging from 5 to 45% sucrose
(freshly prepared in Tris-based buffer). The gradients were centrifuged for
18 h at 40,000 rpm in a SW-50.1 rotor (Beckman Coulter, Fullerton, CA), and
finally 10 fractions were unloaded from the top. Each fraction of the gradient
was further immunoprecipitated with an anti-Golgi-caveolin (anti-Go-cav) or
with anti-PM-cav as described previously.
Photobleaching Experiments and Time-Lapse
Videomicroscopy
FRAP experiments were carried out using a Leica TCS SL laser scanning
confocal spectral microscope (Leica Microsystems Heidelberg, Mannheim,
Germany) with argon and HeNe lasers attached to a Leica DMIRE2 inverted
microscope equipped with an incubation system with temperature and CO2
control. For visualization of GFP, images were acquired using 63 oil im-
mersion objective lens (numerical aperture 1.32), 488-nm laser line, excitation
beam splitter RSP 500, emission range detection 500–600 nm, and the confocal
pinhole set at 2–3 Airy units to minimize changes in fluorescence efficiency
due to proteins/structures-GFP moving away from the plane of focus. The
whole Golgi/lipid bodies/cytoplasm area of a protein transfected cell was
photobleached using 50–80 scans with the 488-nm laser line at full power in
a region of interest. Pre- and postbleach images were monitored at different
intervals for different times. The excitation intensity was attenuated down to
5% of the half laser power to avoid significant photobleaching. Fluorescence
recoveries in the bleached region and overall photobleaching in the whole cell
during the series were quantified using the Image Processing Leica confocal
software. Background fluorescence was measured in a random field outside
of the cells. Fluorescence values were normalized following the methods
described previously (Phair and Misteli, 2000; Dundr et al., 2002). This ex-
pression accounts for the small loss in total intensity caused by the bleach
itself and yields a more accurate estimate of the immobile fraction.
RESULTS
Epitopes of PM-associated Caveolin Are Unmasked upon
Cholesterol Extraction or Methanol Solubilization
We have previously shown that certain caveolin antibodies
exclusively recognize the Golgi pool of the protein and not
the PM pool. This specificity is maintained even upon over-
expression of caveolin to high levels (Luetterforst et al.,
1999). In this work, we investigated this specificity further,
to gain insights into the changes associated with the trans-
port of caveolin to the PM.
A total of six anti-caveolin antibodies were tested in BHK
cells. By Western blotting all the antibodies showed similar
recognition of caveolin (our unpublished data). In contrast, by
immunofluorescence the antibodies showed specificity for dif-
ferent pools of caveolin. PFA/saponin was used as our stan-
dard fixation and permeabilization method. Representative
staining is shown in Figure 1 (see summary in Table 1). Under
these conditions, all antibodies could be classified as recogniz-
ing exclusively the Golgi pool of caveolin (here termed anti-
Go-cav), the PM pool (anti-PM-cav), or both Golgi and PM
pools (anti-cav). For example, the con-cav antibody (anti-Go-
cav) only recognized caveolin associated with the Golgi com-
plex (Figure 1A, arrows), whereas the rbTL antibody (anti-cav)
recognized caveolin present on both the Golgi complex and the
PM (Figure 1D, arrowheads). The specificity of the antibodies
for the caveolin-1 protein was tested in Fischer rat thyroid
(FRT) cells, which lack caveolin-1 (Zurzolo et al., 1994). In FRT
Figure 1. Specific antibodies show affinity for different pools of
caveolin. BHK cells were processed for immunofluorescence mi-
croscopy by using different fixation (PFA/methanol) and permeabi-
lization (saponin/TX-100) protocols. Caveolin distribution was an-
alyzed with two different polyclonal antibodies: anti-Go-cav
antibody (A–C) and anti-cav antibody (D–F). Golgi-associated
caveolin was detected with both antibodies in cells fixed with PFA
and permeabilized with saponin (A and D) but not in cells fixed in
methanol (C and F) or permeabilized with Triton X-100 (B and E).
PM-associated caveolin was detected for anti-caveolin antibody in
all three experimental conditions (D–F). The anti-Go-caveolin anti-
body only detected the PM-associated caveolin when the cells were
fixed with methanol (C) but not PFA (A and B). In total, six anti-
bodies were tested. See Table 1 for a summary of the results and
details of antibodies and protocols. Bar, 5 m.
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cells, the antibodies used in this study (with the exception of
the anti-caveolin-2 reactive antibodies) showed negligible la-
beling (our unpublished data).
To investigate the reason for the different staining patterns,
different fixation/permeabilization conditions were used with
the above-mentioned antibodies. Cells fixed with PFA and
permeabilized with TX-100 showed a dramatically reduced
Golgi staining with all the antibodies (Figure 1B), but the
anti-cav or anti-PM-cav antibodies still detected PM caveolin
(Figure 1E, arrowheads). This suggests that the Golgi pool of
caveolin is sensitive to the fixation/permeabilization condi-
tions because antibodies against the Golgi marker GM130
showed a similar efficiency of labeling in all three fixation/
permabilization conditions (our unpublished data). The most
striking findings were obtained with methanol as the fixation/
permeabilization method. Under these conditions, all antibod-
ies (including anti-Go-cav antibodies) showed PM staining
(Figure 1, C and F).
In view of the documented cholesterol binding properties of
caveolin (Murata et al., 1995) and the above-mentioned finding
that PM caveolin epitopes were revealed upon methanol fixa-
tion, we investigated whether extraction of cholesterol from the
PM would allow normally Golgi-specific antibodies to label the
PM pool. 3T3-L1 adipocytes have abundant caveolae, and
sheets of PMs can be easily prepared from these cells (Robinson
et al., 1992). Cells grown on glass coverslips were sonicated and
the remaining PM attached to the coverslip fixed using either
PFA or methanol before labeling with either anti-cav or anti-
Go-cav antibodies. As in intact cells, only anti-cav antibodies
detected caveolin on the PFA-fixed PM sheets, showing that
the specificity observed in intact cells was maintained (Figure
2B). In contrast, when the PM sheets were fixed with methanol
(Figure 2A), or treated with CD (to extract cholesterol) for 10
min before fixation with PFA, PM-associated caveolin was now
recognized by the anti-Go-cav antibody (Figure 2D) as effi-
ciently as with the anti-cav antibody (Figure 2, B and D). As a
control, labeling with specific antibodies against syntaxin 4 was
shown to be unaffected by the different treatments (Figure 2, A
and D). Note that anti-caveolin antibodies detect caveolae over
the entire PM lawn (which are not resolved and thus exhibit
diffuse labeling) as well as caveolae associated with large
plasma membrane invaginations of the PM. The latter look like
rings and contain other PM markers such as syntaxin 4 (Parton
et al., 2002). From these experiments, we conclude that caveolin
delivery to the PM renders caveolin unreactive to specific
antibodies, but this can be reversed by cholesterol depletion.
We tested whether acute depletion of cholesterol in
living cells causes a similar effect. BHK cells were treated
for 2 h with 2% CD, and the extraction of cholesterol was
visualized by means of filipin staining. Even after 2 h,
surface cholesterol was still visible (Figure 2, E and F).
This treatment did not expose surface epitopes detected
with the anti-Go antibody (Figure 2, G and H). These data
suggest that cells have mechanisms to move cholesterol to
the PM and therefore maintain higher levels of cholesterol
than we achieve by treating isolated PM sheets with CD.
Interestingly, we noted that cells treated with CD showed
stronger caveolin labeling of the Golgi complex (Figure
2H). When the relative fluorescence was quantified, CD-
treated cells showed an increase of 65% in Golgi caveolin-
associated fluorescence (from 1.9  0.7 to 3.1  1.1; Figure
2I; also see Figure 5), but the Golgi marker GM130 was
unaffected (our unpublished data). This result raised the
possibility that cholesterol regulates the exit of caveolin
from the Golgi complex.
Transit of Newly Synthesized Caveolin through the Golgi
Complex
We took advantage of the specificity of the anti-Go-cav
antibodies for the Golgi-associated caveolin to more closely
examine the traffic of the protein through this compartment.
BHK cells were incubated for different times with a general
inhibitor of protein translation, Cyhx, and the Golgi-associ-
ated pool of caveolin were monitored by means of an anti-
Go-cav antibody. A reduction in the amount of protein (59
16%) was evident after 1 h of incubation with Cyhx (Figure
3, B and G, for quantification), and caveolin was almost
undetectable (10  8%) after 3 h (Figure 3C). Interestingly,
even after prolonged incubation with Cyhx, a low level of
caveolin was detected in the Golgi complex of some cells.
This may represent a permanent or recycling pool of the
protein as Cyhx caused a complete block in protein synthesis
as shown in control experiments (our unpublished data).
When cells were incubated with Cyhx at 15°C (which inhib-
its both ER/Golgi transport and post-Golgi transport) or
20°C (which inhibits post-Golgi transport), no detectable
reduction in the levels of caveolin in the Golgi was observed
(our unpublished data). This is consistent with exit of a
significant fraction of caveolin from the Golgi complex via a
membrane trafficking pathway, but further work is required
to examine whether a vesicular transport pathway is in-
volved. These results also demonstrate that accessibility of
caveolin to the antibodies is not modified during the incu-
bation with Cyhx. Further support for this comes from the
observation that the anti-cav antibody no longer detects the
protein in the Golgi complex after Cyhx treatment (our
unpublished data). Very similar kinetics was obtained in
response to puromycin, a different inhibitor of protein trans-
lation (our unpublished data).
Next, we analyzed the movement of the newly synthesized
caveolin to the Golgi complex. BHK cells were incubated for
3 h with Cyhx, to clear the biosynthetic pool of caveolin, then
the drug washed out allowing caveolin expression to resume.
After recovery at 37°C, caveolin reappeared in the Golgi com-
plex (Figure 3D). The recovery (quantified as percentage of
pixel intensity with respect to control cells; Figure 3G) reached
half of the original intensity after 30 min (43 12) (Figure 3D).
This recovery was completely blocked at 15°C (Figure 3F) but
not at 20°C (Figure 3E).
Caveolin in the Golgi Complex Is in Low-Molecular-
Weight Oligomers and Is Soluble in Triton X-100 at Low
Temperature
To confirm and extend the results obtained by immunoflu-
orescence microscopy, we developed a biochemical method
to isolate Golgi caveolin. We took advantage of the fact that
the Golgi-associated pool of caveolin in unfixed cells is
soluble in a low concentration of TX-100 at low temperature,
in contrast to the PM-associated protein that is largely, but
not completely, insoluble (see below). For these experi-
ments, BHK cells were extracted at 4°C with a buffer con-
taining 0.1% TX-100. Under these conditions the Golgi-asso-
ciated caveolin was largely extracted (compare Figure 4A
with B, and E with F) compared with caveolin on the PM as
judged by immunofluorescence microscopy (compare Fig-
ure 4C with D, and E with F). Therefore, cells were treated
for 1, 2, or 3 h with Cyhx at 37 or 20°C and extracted in 0.1%
TX-100. After extraction, the soluble protein was immuno-
precipitated with an anti-Go-cav antibody (see Materials and
Methods for details). In agreement with the results shown in
Figure 3, the amount of caveolin solubilized from the Golgi
decreased progressively in response to Cyhx (Figure 4G).
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Figure 2. Cholesterol depletion reveals specific epitopes of caveolin. Plasma membrane sheets were prepared from 3T3-L1 adipocytes and
fixed immediately in MeOH (A) or PFA (B) or incubated in 0.4% CD for 5 min (C) or 10 min (D) before PFA fixation. Membranes were
single-labeled using anti-cav or double-labeled using anti-Go-cav and anti-syntaxin4. Anti-cav recognized caveolin on the PM in both PFA-
and MeOH-fixed membranes. Anti-Go-cav recognized caveolin on the PM only when the membranes were fixed with MeOH (E) or extracted
with CD for 10 min before fixation with PFA (D), whereas anti-Syn4 labeled both PFA- and MeOH-fixed membranes. (E–I) BHK were treated
for 2 h with 2% CD, and the distribution of cholesterol was studied by means of filipin (F). Even after 2 h, surface cholesterol was still visible
(compare E with F). After the CD treatment, and in contrast to the results obtained for plasma membrane sheets, anti-Go-cav do not
recognized caveolin on the PM (H); however, a stronger caveolin labeling of the Golgi complex was observed (compare H with G). (I) The
relative fluorescence associated with caveolin in the Golgi-complex was quantified in control and CD-treated cells. CD-treated cells showed
an increase of 65% in Golgi caveolin-associated fluorescence. Bar, 5 m.
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When the cells were incubated at 20°C for 3 h, the amount of
caveolin immunoprecipitated increased consistent with con-
tinued traffic from the ER but reduced exit from the Golgi.
No change in immunoprecipitated caveolin was observed in
response to incubations with Cyhx in cells maintained at
20°C. In addition, no changes in immunoprecipitated caveo-
lin was observed when the extracted material was immuno-
precipitated with an anti-PM-cav antibody after various
times of Cyhx treatment (Figure 4H). These results validate
the isolation method which was then used to specifically
study the properties of Golgi-associated caveolin.
Control cells or cells treated for 3 h with Cyhx were extracted by
immersion in a buffer that contained 0.1% TX-100 at 4°C, and the
soluble supernatant was fractionated using a sucrose gradient to
separate the different molecular weight oligomers of caveolin (see
Materials and Methods for details). Fractions were unloaded from
the top of the gradient, and each fraction was immunoprecipitated
using anti-Go-cav or anti-PM-cav. Finally, the caveolin immuno-
precipitated from each fraction was detected by Western blotting
(Figure 4I). The anti-Go-cav antibody recognized predominantly
low-molecular-weight oligomers of the protein (fractions 1 and 2
of the gradient). In agreement with the results shown previously,
the caveolin pool recognized by the anti-Go-cav antibody dimin-
ished in response to the treatment with Cyhx. In contrast, the
anti-PM-cav antibody exclusively recognized the high-molecular-
weight caveolin complexes (fractions 3–5). Although PM-associ-
ated caveolin is largely insoluble in the detergent, a small amount
of high-molecular-weight oligomers of caveolin that was not af-
fected by the presence of Cyhx was present in the soluble super-
natant. This pool of protein, presumably released by mechanical
extraction rather than being soluble in the detergent, was used as
a control for the specificity of the anti-Go antibodies.
Cholesterol Modulates Caveolin Traffic through the Golgi
Complex
Caveolin is both a cholesterol and fatty acid binding protein
and has been suggested to be involved in the intracellular
transport of lipids. In view of the above-described studies
suggesting that Golgi exit is associated with cholesterol
binding, we investigated whether cholesterol modulates
caveolin traffic by taking advantage of the above-mentioned
methods to look at the Golgi-associated caveolin pool.
Cells were incubated for 2 h in a medium enriched in cho-
lesterol. Protein translation was inhibited using Cyhx, and the
transport of caveolin out of the Golgi complex was monitored
using the anti-Go-cav antibody. In the presence of elevated
cholesterol, the rate of decrease in the Golgi caveolin pool
observed after treatment with Cyhx was accelerated from 25
9 to 11  3% (Figure 5, D and E, for quantification). We
calculated that the half-life of Golgi caveolin was 70 min in
control cells in contrast to 42 min in cells treated with choles-
terol (Figure 5E). The findings were confirmed using a bio-
chemical approach. Cells were incubated with cholesterol for
90 min, and the amount of soluble caveolin that could be
immunoprecipitated by the anti-Go-cav antibody was deter-
mined as described in Figure 4. In agreement with the immu-
nofluorescence microscopy less caveolin was present in the
Golgi complex of cells treated with cholesterol, accelerating the
effect of Cyhx (Figure 5F). The changes promoted by choles-
terol addition were inhibited at 20°C, suggesting that choles-
terol modulates the exit of caveolin out of the Golgi complex. In
contrast, and in accordance with the data shown in Figure 2,
when the cells were treated with 2% CD (to deplete choles-
terol), more caveolin accumulated in the Golgi complex, reduc-
ing the effect of Cyhx (Figure 5G).
Time-Lapse Videomicroscopy of Caveolin Traffic through
the Golgi Complex
To extend these results and to examine whether a non-
caveolar membrane protein shows similar changes in
transport, we directly studied the transport of a GFP-
tagged caveolin-3 construct compared with the transport
of the raft-excluded VSV-G tagged with GFP by time-
lapse videomicroscopy. Caveolin-GFP constructs traffic to
caveolae in an identical manner to wild-type caveolins
(Pelkmans et al., 2001, 2002; Thomsen et al., 2002). Caveo-
lin-3 also associates with caveolae when expressed in
nonmuscle cells (Way and Parton, 1995), but it has the
advantage of not oligomerizing with endogenous caveo-
lin-1 (Song et al., 1997). The proteins were transfected into
BHK cells, and after 6 h cells were selected for the pres-
ence of Cav3-GFP or VSV-G-GFP in the Golgi area. At this
very short time point after the transfection, caveolin and
VSV-G were commonly observed in the Golgi complex.
Next, Cyhx or a combination of Cyhx/cholesterol was
added to the media, and images were captured at inter-
vals of 20 min. After 60-min incubation with Cyhx, the
levels of Golgi-associated caveolin decreased to 59  1%
of the initial levels (see representative experiment in Fig-
ure 6, A and B). Identical results were obtained when a
C-terminally yellow fluorescent protein-tagged caveolin 1
was studied (our unpublished data). In agreement with
Figure 3. Golgi-associated caveolin predominantly corresponds to
newly synthesized protein. BHK cells were incubated for different times
with Cyhx (a general inhibitor of protein translation), and the Golgi-
associated pool of caveolin was monitored by means of an anti-Go-cav
antibody. The amount of caveolin present in the Golgi complex was
quantified as percentage of pixel intensity with respect to control cells (G).
A reduction to 59 16 or 10 8% in the amount of caveolin was detected
after 1 h (B) or 3 h (C), respectively. Next, the cells were incubated for 3 h
with Cyhx, and the drug was washed out, allowing the cells to recover.
After 30 min at 37°C, 43  12% of caveolin reappeared in a the Golgi
complex (D). The recovery was completely blocked at 15°C (7  1%) (F)
but unaffected at 20°C (46  14%) (E). Bar, 5 m.
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the results shown in Figures 4 and 5, treatment with Cyhx
and cholesterol further diminished the levels of caveolin
in the Golgi complex to 27  6% (Figure 6, C and D; also
see average quantitation and time course in Figure 6E). In
the presence of Cyhx, the levels of Golgi-associated VSGV
were reduced to 74  12% of the initial levels, indicating
that VSV-G transits more slowly than caveolin through
the Golgi complex. In striking contrast to caveolin, cho-
lesterol addition did not accelerate the transport of VSV-G
(71  14%; see quantification in Figure 6E).
Next, we compared the trafficking of wild-type Cav3 to the
trafficking of an epitope-tagged form of Cav3P104L, a caveolin
mutant associated with muscle diseases that shows aberrant
trafficking through the Golgi complex (see Introduction).
Cav3P104L accumulated in the Golgi complex when expressed
in BHK cells (our unpublished data) as observed in other
nonmuscle cells (Galbiati et al., 1999). We used time-lapse
videomicroscopy to examine whether the transport of the mu-
tant caveolin out of the Golgi complex is affected by cholesterol
addition. As shown in Figure 6, F and G, when the cells were
treated with Cyhx, Cav3P104L-GFP was less stable than the
wild-type protein and diminished after 1 h to 31  5% of the
original intensity. In striking contrast to the wild-type protein
(Figure 6, H and I), cholesterol addition retarded the loss of the
mutant protein from the Golgi complex (54  6%) (see Figure
6J for the quantitation of 6 experiments), consistent with an
Figure 4. Golgi caveolin is deter-
gent soluble and forms low-molecu-
lar-weight oligomers. BHK cells were
extracted for 2 min at 4°C with a
buffer containing 0.1% TX-100, fixed
in PFA, and caveolin was detected
with an anti-Go-cav or an anti-PM-
cav antibody. The Golgi pool of
caveolin was completely extracted by
the detergent (compare A and B or E
and F), but the PM pool was largely
unaffected (compare C and D or E
and F). In G, BHK cells were treated
for 1, 2, or 3 h with Cyhx at 37 or
20°C, extracted for 2 min at 4°C with
a buffer containing 0.1% TX-100, and
the soluble fraction was immunopre-
cipitated with anti-Go-cav antibody.
The amount of caveolin decreased
progressively in response to Cyhx,
and little protein was detected after
3 h. When the cells were incubated at
20°C, the amount of caveolin immu-
noprecipitated increased. At 20°C, no
effect was observed in response to
Cyhx consistent with retention in the
Golgi complex. No changes in re-
sponse to Cyhx were observed with
an anti-PM-cav antibody (H). (I) Con-
trol cells or cells treated for 3 h with
Cyhx were extracted with 0.1% TX-
100, and the different molecular
weight oligomers of caveolin were
fractionated using a sucrose gradient
(see Materials and Methods for details).
Fractions of the gradient were immu-
noprecipitated using anti-Go-cav or
anti-PM-cav. The anti-Go-cav anti-
body recognized predominantly low-
molecular-weight oligomers of the
protein (fractions 1 and 2 of the gra-
dient), but the anti-PM-cav antibody
exclusively recognized the high-mo-
lecular-weight caveolin complexes
(fractions 3–5). In contrast to the PM
pool of the protein, Golgi caveolin
was sensitive to Cyhx. Bar, 5 m.
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effect of cholesterol on Golgi exit and/or on stability of the
Cav3P104L protein.
FRAP of Golgi-associated Caveolin
The above-mentioned results demonstrate that the Golgi-
associated pool of caveolin is mainly derived from newly
synthesized protein that transits the Golgi complex in a
process regulated by cholesterol. Next, we investigated the
post-Golgi trafficking of caveolin by studying the recovery
after photobleaching of GFP-tagged caveolin. Cav3-GFP was
transfected into Vero cells. After 16 h, the fluorescence of
selected cells was photobleached, excluding the Golgi area,
and then incubated with Cyhx and cholesterol as described
previously (see Video 1 and Figure 7, A and B). Within the
first minutes after photobleaching, numerous labeled ele-
ments were observed budding from the Golgi complex and
trafficking toward the PM (Figure 7D, arrows). Fluorescence
at the PM recovered after 10–15 min, and the labeling pro-
gressively increased during the rest of experiment (Figure 7,
C and D, arrowheads). In agreement with the results ob-
tained by conventional time-lapse videomicroscopy (Figure
6), the Golgi pool of caveolin decreased to 20  5% of the
original levels after 1-h incubation in the presence of choles-
terol and Cyhx (Figure 7, C and D).
Caveolin Cycles between the PM, the Golgi Complex, and
Intracellular Lipid Bodies
So far, we have described the intracellular transport of
newly synthesized caveolin through three compartments;
from the ER into the Golgi complex and from the Golgi
complex, after cholesterol binding and oligomerization of
the protein, to the PM. Next, we investigated whether the
PM pool of caveolin traffics into other intracellular or-
ganelles. It is generally assumed that the pool of caveolin-1
at the cell surface is relatively immobile unless the cells are
perturbed experimentally. For example, we have previously
Figure 5. Cholesterol modulates caveolin traffic through the Golgi complex. BHK cells were incubated for 2 h in a medium enriched in
cholesterol (C), with CyHx (B) or with both (D). The Golgi-associated caveolin was monitored by means of anti-Go-cav antibody. In the
presence of elevated cholesterol, the rate of decrease in the Golgi caveolin pool observed after treatment with Cyhx was accelerated from 25
9 to 11  3% (D and E for quantification). (F and G) Cells were incubated for 90 min with cholesterol or cyclodextrin, Cyhx, or both, and
detergent-soluble caveolin was immunoprecipitated by anti-Go-cav antibody. Less caveolin was precipitated from cells treated with
cholesterol. However, few changes in the amount of caveolin were observed when the Golgi exit was blocked at 20°C. (G) In contrast, more
caveolin was immunoprecipitated from cells treated with 2% CD. Bar, 5 m.
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shown that caveolin accumulates in intracellular LBs in re-
sponse to the lipid loading of the cells (Pol et al., 2001, 2004).
Cav3-GFP was transfected into BHK cells for 3 h (see scheme
of the sequence of treatments in Figure 8). At this time point,
the transfected protein was visible in the characteristic tubules
of the ER (Figure 8A, open arrows) and in the Golgi complex
(Figure 8A, arrowheads). In addition, in some cells, a low level
of fluorescence was detected on the PM (Figure 8A, open
triangles). Next, the transfection mixture was washed out and
replaced by a medium that contained Cyhx to inhibit the
Figure 6. Cholesterol increases transport through the Golgi complex of caveolin but not of VSV-G. BHK cells were transfected with
Cav3-GFP for 6 h or with VSV-G-GFP induced at 31°C for 3 h. Cells were selected for the presence of the protein in the Golgi area. Next,
Cyhx/cholesterol was added to the media. The focus of the microscope was then kept constant during the rest of the experiment. Images were
captured every 1 min during 60 min and processed equally to calculate the integrated intensity (the product of the area and the average pixel
intensity) (see representative experiment in A–D and average of 6 independent experiments in E). After 1 h, Cav1 levels were reduced to 59
10% in response to Cyhx (compare B with A) and to 27  6% in response to Cyhx/cholesterol (compare D with C and see E for the complete
time course). In contrast, no significant differences were observed in the levels of Golgi associated VSV-G after 1 h with Cyhx (75  12%) or
with Cyhx/cholesterol (71  14%) (E). (F–J) Cells were transfected with Cav3P104L-GFP and treated with Cyhx or with a combination of
Cyhx and cholesterol as described previously (see representative experiment in F–I and average of 6 independent experiments in J). In
contrast to the wild-type protein, cholesterol addition retarded the loss of the mutant Cav3P104L-GFP from the Golgi complex (from 30.5 
5 to 54.2  6%). Bar, 5 m.
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synthesis of new protein, and the transfected protein was
chased out for 3 h. In agreement with the dynamics of the
endogenous protein, caveolin was not visible in the ER or in the
Golgi complex but distributed in a characteristic scattered pat-
tern on the PM after 3 h of Cyhx treatment (94 4% of the cells;
Figure 8B, open triangles). In a few cells, the transfected protein
was permanently retained in the membranes of ER and in
intracellular lipid bodies (2  1%) or was still visible in a
perinuclear location of the cell (4 1%). At this time point, the
cells were incubated with 50 g/ml oleic acid, in the presence
of Cyhx, for an additional 6 h. After the treatment, caveolin was
still present on the PM of the cells (96 3% of the cells) (Figure
8B, open triangles), but in addition it was commonly observed
on the periphery of intracellular LBs (65  7% of the cells)
(Figure 8C, arrows). These results strongly suggest the exis-
tence of an intracellular pathway, followed by caveolin, be-
tween the PM and LBs.
Next, we analyzed whether caveolin can follow a reverse
pathway between the LBs and the PM. For this experiment,
Cav3-GFP was transfected for 2 h in the presence of brefel-
din A (BFA) to inhibit the exit of the synthesized protein out
of the ER. The transfection mixture was washed out and
replaced for an additional 2 h by a medium that contained
Cyhx and BFA. After this treatment, Cav3-GFP was exclu-
sively detected in lipid bodies (95  1% of the cells; Figure
8D, arrows). Finally, BFA was washed out, and the trans-
fected protein was chased out in the presence of Cyhx. After
2 h, caveolin was still observed in intracellular LBs in few
cells (18 5%). However, in the majority of cells (89 14%),
the bulk of the protein was present on the PM (Figure 8E,
open triangles). In addition to the PM, in 73  8% of the
cells, caveolin was observed in the Golgi complex (Figure
8E, arrowheads). Some cells (11  2%) were not able to
recover, and caveolin remained exclusively in LBs.
Figure 7. FRAP of Golgi-associated caveolin. Cav3-
GFP was transfected into Vero cells. After 16 h, the
fluorescence of selected cells (A) was photobleached
excluding the Golgi area (B), and then incubated with
Cyhx and cholesterol for 1 h (see Video 1). Frames were
taken every 10s. Within the first minutes after the pho-
tobleaching, numerous vesicles were observed budding
from the Golgi complex and trafficking toward the PM
(D). Fluorescence at the PM recovered during the exper-
iment (C and D, arrowheads), but Golgi pool of caveolin
decreased to 20  5% (C and D). Bar, 5 m.
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Lipid Body-associated Caveolin Represents a Dynamic
Pool of the Protein
The above-mentioned results strongly suggest that the same
caveolin molecule can cycle between LBs, the PM, and the
Golgi complex. This suggests that specific mechanisms must
exist for targeting of caveolin to LBs and for retrieval of
caveolin in response to changes in the cellular lipid balance.
We therefore investigated the dynamics of LB-associated
caveolin by using time-lapse videomicroscopy and FRAP.
Vero cells were transfected with Cav3-GFP for 16 h (Figure
9A). At this time point, caveolin was commonly detected in
LBs. Caveolin-containing LBs usually aggregated, forming
grape-like structures (Figure 9, C and D, and Video 2). To better
resolve the dynamics of caveolin in LBs images were captured
every 10 s for a total period of 60 min. Two different popula-
tions of LBs were observed. One population of LBs only
showed a short-range rotary movement (Figure 9E, arrows,
and Video 4). The second population showed, in addition, a
long range movement underneath the PM (Figure 9E, arrow-
heads, and Video 4). After photobleaching LB fluorescence
recovered rapidly and often reached half of the original inten-
sity in1 h (Figure 9, F and G, and Video 2). In addition to the
translation movement other processes were commonly ob-
served. First, we noted the budding of tubules from LBs that
apparently contacted the PM (Figure 9H and Video 3). Second,
we observed shuttling of small/group of LBs from larger LBs
(Figure 9I and Video 3) and possible fusion processes between
LBs (Figure 9J and Video 2).
Finally, we studied the rate of FRAP of LB-associated caveo-
lin (Videos 5 and 6 and Figure 10). In these experiments cells
were transfected with cav3-GFP and incubated for 24 h with 50
g/ml oleic acid to induce the formation of enlarged LBs.
Then, cells were completely photobleached, excluding the pe-
ripheral PM. Photobleached LBs recovered 21  3% of the
original fluorescence within 1 h (Figure 10, A and B, and Video
5), even in the presence of Cyhx, to inhibit the synthesis of new
protein (17  1%; Figure 10, C and D, and Video 6). To
completely clear the biosynthetic pool of caveolin in these
experiments, cells were preincubated with Cyhx for 1 h and
during the whole experiment. These results clearly demon-
strate that the transit of full-length caveolin to and from LBs is
extremely dynamic.
DISCUSSION
In this study, we have shown for the first time that the kinetics of
transport of caveolin out of the Golgi complex is regulated by
cholesterol, suggesting an additional level of complexity in caveo-
Figure 8. (A–C) Caveolin cycle. (A) BHK cells were transfected with Cav3-GFP for 3 h. (B) Next, the transfection medium was replaced by
a medium containing Cyhx, and the cells were incubated for an additional 3 h. (C) Finally, 50 g/ml oleic acid was added for 6 h. (D and
E) BHK cells were transfected with Cav3-GFP for 2 h in the presence of 5 g/ml BFA. Next, the transfection medium was replaced by medium
that contained Cyhx and BFA for an additional 2 h (D). Finally, BFA was washed out, and the cells were further incubated in a media
containing Cyhx for 2 h (E). Bar, 5 m.
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lin regulation. Delivery of caveolin to the cell surface is associated
with loss of reactivity to specific caveolin antibodies, and we now
show that this can be reversed by cholesterol depletion. A mus-
cular dystrophy-associated mutant of caveolin-3 is retained in the
Golgi complex and in contrast to the wild-type protein is stabi-
lized by cholesterol addition. Moreover, we have shown that
caveolin can move from the PM to associate with LBs in response
to lipid addition. The LB pool of caveolin is very dynamic and can
move to the PM when the lipid source is removed. Thus, caveolin
can act as a sensor of cellular lipid levels. This study provides new
insights the handling of lipids and the trafficking of caveolin by
cells, and it reinforces the importance of lipid bodies as a dynamic
cellular organelle.
Cholesterol Depletion Increases PM Reactivity to Specific
Caveolin Antibodies
It has been known for some time that specific antibodies to
caveolin preferentially label the Golgi pool of the protein.
We now show that this is a property of antibodies against
several different regions of the protein (N terminus, caveolin
scaffolding domain, and C terminus), and the specificity is
dependent on the fixation/permeabilization conditions
used. We also show for the first time that CD treatment of
plasma membrane sheets reveals epitopes in surface caveo-
lin and allows their recognition by these antibodies. This
effect was not seen in intact cells, presumably because cel-
lular mechanisms exist to maintain PM cholesterol at higher
levels than in CD-treated sheets. A number of effects of
cholesterol extraction could explain these results. For exam-
ple, cholesterol removal could directly expose sites involved
in cholesterol binding, cause conformational changes in
caveolin, decrease caveolin oligomerization, or remove other
raft-associated molecules that interact with caveolin. Oli-
gomerization can occur in the ER, at least in vitro (Monier et
al., 1995), but the acquisition of detergent insolubility asso-
ciated with lipid raft localization is thought to occur late in
the Golgi complex (Scheiffele et al., 1998). In fact, the Golgi
pool of caveolin in cultured cells is preferentially removed
by detergent preextraction before fixation, suggesting that
the bulk of Golgi-associated caveolin is detergent soluble.
Intriguingly, a very recent study has shown that a common
feature of a range of different caveolin mutants that accu-
mulate in the Golgi complex is their detergent solubility
(Ren et al., 2004). This is consistent with the idea that lipid
raft association might be required for efficient forward trans-
port of caveolin in the Golgi complex, which also would be
consistent with the accelerated transport of caveolin in re-
sponse to cholesterol addition.
Cholesterol Regulates Traffic of Newly Synthesized
Protein through the Golgi Complex
Caveolin has been assumed to recycle to the Golgi complex
from the cell surface, accounting for the intracellular pool of the
protein in the presence of continual exit of caveolins in exocytic
vesicles. Consistent with previous studies (Nichols, 2002), we
showed that this pool was sensitive to cycloheximide, suggest-
ing that it largely corresponds to newly synthesized protein.
This allowed us to follow the transport of endogenous caveolin
from its site of synthesis to the PM via the Golgi complex. We
found that transport was regulated by the lipid content of the
cell. Cholesterol addition accelerates transport through the
Golgi complex and cholesterol depletion retards transport. The
specificity of this effect was shown by the fact that transport of
the nonraft integral membrane protein VSV-G was not affected
Figure 9.
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by cholesterol addition. This rules out nonspecific effects of
cholesterol on the Golgi complex, as shown in recent studies
(Ying et al., 2003).
The physiological role of the accelerated transport of caveo-
lin upon cholesterol addition remains to be established, but this
is an interesting possibility in view of the reported links be-
tween caveolin-1 and cholesterol. We have demonstrated that
the expression of a caveolin dominant negative mutant induces
a cholesterol imbalance in the cell and reduces the levels of
cholesterol on the PM (Pol et al., 2001). Caveolin-1 expression is
regulated by cholesterol at the transcriptional level (Bist et al.,
1997, 2000; Fielding et al., 1997; Hailstones et al., 1998), so cells
can respond to changes in free cholesterol. An added level of
complexity is shown here; free cholesterol also regulates the
amount of caveolin-1 reaching the PM independent of caveolin
synthesis. Together with previous studies showing regulation
of caveolin-1 protein levels throughout the cell cycle (Fielding
et al., 1999), this indicates several levels of regulation of caveo-
Figure 9 (cont). Time-lapse videomicroscopy and FRAP of LB-associated caveolin. Vero cells were transfected with Cav3-GFP for 16 h (A),
after photobleaching of the cell, except the PM (see example in B) images were captured every 10 s for a total period of 60 min. Caveolin
containing LBs usually aggregated forming grape-like structures (C, confocal section D, and Video 2). Some LBs showed a short-range rotary
movement (E, arrows, and Video 4), whereas others showed a long-range movement underneath the PM (E, arrowheads, and Video 4). After
photobleaching, LBs recovered rapidly and often reached half of the original intensity in 1 h (F and G and Video 2). We also noted the
budding of tubules from LBs that apparently contacted the PM (H and Video 3), shuttling of small/group of LBs from larger LBs (I and Video
3), and possible fusion processes between LBs (J and Video 2). Bar, 2 m.
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lin by cholesterol. Caveolin-1 could therefore act as a sensitive
cholesterol sensor. Increased caveolin expression at the PM
may act as a mechanism to increase free cholesterol efflux at
early time points of cholesterol increase, which is subsequently
followed by increased protein synthesis.
Dynamic and Regulated Two-Way Trafficking of Caveolin
between the Cell Surface and Lipid Bodies
Previous studies have shown that caveolin accumulates within
LBs in response to fatty acid loading (Liu et al., 2004; Pol et al.,
2004). However, although it is clear that newly synthesized
caveolin can reach LBs via the ER (Ostermeyer et al., 2001) or
via the Golgi complex (Pol et al., 2004), is it possible for caveolin
to redistribute from the cell surface to LBs? This pathway could
play an important role in linking PM lipid levels to the major
site of cellular lipid storage, the LB. To test this, we optimized
conditions in which caveolin was associated exclusively with
the PM pool before fatty acid addition. We observed a striking
redistribution of PM caveolin in response to oleic acid. Control
experiments showed a complete block in protein synthesis
under these conditions arguing against ER-derived caveolin
being the source of caveolin in LBs. Using a similar strategy, we
examined a related crucial issue; can LB-associated caveolin be
retrieved from LBs and reach the PM after fatty acid removal?
Our results strongly suggest that this is indeed the case and
that the LB is just one potential station in the caveolin cycle.
Thus, the LB is not a dead-end, as has been suggested previ-
ously, but mechanisms exist to transport caveolin from the LBs.
The elucidation of this caveolin cycle strengthens the pro-
posed role of caveolin and LBs in cellular lipid regulation.
However, the mechanisms by which caveolin redistributes in
response to fatty acid addition/removal are as yet unclear. The
intramembrane region of caveolin has been implicated in LB
association (Ren et al., 2004). Fatty acids may regulate the
exposure of this domain through conformational changes in
caveolin or may trigger interactions with other proteins. The
results strengthen the view that LBs are a very dynamic struc-
ture with traffic to and from these structures. Real-time studies
of caveolin trafficking reinforce this view. Cav3-GFP labeled
structures constantly bud from the LBs. We also noted prox-
imity of caveolin-containing LBs to the cell surface and appar-
ent interactions with the PM. Our studies raise the possibility
that interactions with the PM might facilitate exchange be-
tween these two compartments, consistent with the previously
proposed view that regulating the lipid composition of the PM
may involve caveolins and LBs. The present findings that
caveolin can cycle between these two structures, redistributing
from one to the other in response to lipid balance, together with
previous findings that a caveolin mutant disrupts surface lipid
raft domains while associating with, and perturbing LBs (Roy
et al., 1999; Pol et al., 2001, 2004), are all consistent with this
hypothesis. Elucidation of the mechanisms involved will prove
to be an exciting avenue of future research relevant to both
cellular lipid regulation and signal transduction.
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